ALL

ALLSTATE CORP
2 filings tracked
financialsinsuranceLARGE ($10B-200B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

The investment narrative has shifted from a defensive posture to one of aggressive operational optimization.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Critics argue that the perceived turnaround is a mirage built on non-recurring accounting gains and a fragile investment portfolio.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every ALL filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Allstate's latest financial disclosures reveal a company in the midst of a high-stakes transition, attempting to decouple its earnings profile from the inherent volatility of property and casualty insurance.…

Latest Available Quarter (Q2 '26 (10-Q))

Core Takeaway

Allstate achieved a massive earnings beat, but the quality of earnings is questioned due to a large reserve release.

Investor Lens

The trade-off between a leaner cost structure and the sustainability of earnings.

Watch Next

Q2 2026 combined ratio without the benefit of prior-year reserve releases.

Calculated Financial Trajectory (Click to filter signals)

Net Income / Loss$2457M
the quarter ended March 31, '26: $2457M

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.30Q1 '26 (10-K)+0.45Q2 '26 (10-Q)

Signal Timeline

bullishApr 29

Net income surged to $2.46 billion driven by underwriting gains.

earnings beat
90%
bullishApr 29

Combined ratio improved to 82.0% from 97.4% year-over-year.

margin expansion
80%
bullishApr 29

Authorized a new $4 billion share repurchase program.

buyback
70%
bearishApr 29

Aggressive buybacks are being funded amid negative operating cash flow.

dilution risk
60%
bullishFeb 20

Combined ratio improved to 85.2% from 104.5% two years prior.

margin expansion
80%
bullishFeb 20

Completed divestiture of voluntary benefits and group health businesses.

divestiture
60%
bearishFeb 20

Facing non-renewal moratoriums and rate caps in California and Texas.

regulatory action
70%
bullishFeb 20

Authorized $1.5 billion in share repurchases to return capital.

buyback
50%

Filing History

10-QApr 29, 2026
Expand Sequence

The Q1 2026 filing presents a company at a crossroads, balancing a powerful underwriting recovery against fragile cash flow and investment metrics. While the collapse of the combined ratio and the resulting earnings explosion are bullish signals, the reliance on one-time reserve releases creates a high bar for sustainable future performance. Investors are left to weigh the benefits of aggressive capital returns and improved pricing power against the reality of negative operating cash flow. The overall impact of the filing suggests a firm that has optimized its cost structure but remains exposed to significant macroeconomic and valuation risks.

10-KFeb 20, 2026
Expand Sequence

The 2025 10-K reveals a company at a critical crossroads, attempting to trade the volatility of the insurance industry for the stability of a diversified financial services model. While the financial results show a dramatic surge in net income and a successful operational pivot, these gains are tempered by a complex web of derivative liabilities and tightening regulatory environments in major states. The company's ability to maintain its 'fortress' status depends on the successful execution of AI-driven underwriting and the stability of its illiquid investment portfolio. Ultimately, the filing highlights a tension between aggressive capital returns and the need for a robust capital cushion. The divestiture of non-core assets and the improvement in the combined ratio are positive signals, but systemic risks from climate-driven catastrophes and state-mandated rate freezes remain. Investors must weigh the potential for a high-margin fee-based future against the immediate fragility of the company's regulatory and liquidity profile.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.